News
-
-
-
-
-
-
PRESS RELEASE
Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance; Sustained growth dynamic anticipated for 2025-2026
Exosens delivers very strong full-year 2024 results, overperforming on its IPO guidance, with sustained growth dynamic anticipated for 2025-2026. Significant increase in profitability with best-in-class margin -
-
-
-